Supernus Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on Supernus Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Supernus Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Supernus Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Supernus Pharmaceuticals Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 19 Dec 2023 | Knight Therapeutics Enters into Licensing Agreement with Supernus Pharma | Licensing Agreement |
Knight Therapeutics Inc
|
Supernus Pharmaceuticals Inc |
| 19 Oct 2021 | Supernus Pharmaceuticals Inc Enters Phase 0 Clinical Trial Agreement with Nucleus Network Ltd for SPN-817 (GDCT0438100) | Contract Service Agreement |
Supernus Pharmaceuticals Inc
|
Nucleus Network Ltd
|
| 11 Oct 2021 | Supernus Pharma Acquires Adamas Pharma | Acquisition |
Supernus Pharmaceuticals Inc
|
Adamas Pharmaceuticals Inc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer